These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 2437457)
1. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Gotch F; Rothbard J; Howland K; Townsend A; McMichael A Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457 [TBL] [Abstract][Full Text] [Related]
2. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein. Engelhard VH; Lacy E; Ridge JP J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033 [TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73. Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444 [TBL] [Abstract][Full Text] [Related]
4. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Bodmer H; Ogg G; Gotch F; McMichael A Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838 [TBL] [Abstract][Full Text] [Related]
5. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Martinon F; Gomard E; Hannoun C; Lévy JP Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754 [TBL] [Abstract][Full Text] [Related]
6. Analysis of a naturally occurring HLA class I-restricted viral epitope. Falk K; Rötzschke O; Stevanović S; Gnau V; Sparbier K; Jung G; Rammensee HG; Walden P Immunology; 1994 Jul; 82(3):337-42. PubMed ID: 7525458 [TBL] [Abstract][Full Text] [Related]
7. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity. Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941 [TBL] [Abstract][Full Text] [Related]
8. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560 [TBL] [Abstract][Full Text] [Related]
9. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182 [TBL] [Abstract][Full Text] [Related]
10. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. Bednarek MA; Sauma SY; Gammon MC; Porter G; Tamhankar S; Williamson AR; Zweerink HJ J Immunol; 1991 Dec; 147(12):4047-53. PubMed ID: 1721637 [TBL] [Abstract][Full Text] [Related]
11. Specificity of peptide binding by the HLA-A2.1 molecule. Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes. Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117 [TBL] [Abstract][Full Text] [Related]
13. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2. Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387 [TBL] [Abstract][Full Text] [Related]
14. Competition between unrelated peptides recognized by H-2-Kd restricted T cells. Pala P; Bodmer HC; Pemberton RM; Cerottini JC; Maryanski JL; Askonas BA J Immunol; 1988 Oct; 141(7):2289-94. PubMed ID: 2459204 [TBL] [Abstract][Full Text] [Related]
15. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681 [TBL] [Abstract][Full Text] [Related]
16. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326 [TBL] [Abstract][Full Text] [Related]
17. Two epitopes and one agretope map to a single HLA-A2 peptide recognized by H-2-restricted T cells. Martinon F; Cornille F; Gomard E; Fournie-Zaluski MC; Abastado JP; Roques BP; Levy JP J Immunol; 1989 May; 142(10):3489-94. PubMed ID: 2469716 [TBL] [Abstract][Full Text] [Related]
18. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice. Man S; Ridge JP; Engelhard VH J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521 [TBL] [Abstract][Full Text] [Related]
19. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010 [TBL] [Abstract][Full Text] [Related]
20. Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides. Nijman HW; Houbiers JG; van der Burg SH; Vierboom MP; Kenemans P; Kast WM; Melief CJ J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):121-6. PubMed ID: 7506574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]